Stress related disorders
Conditions
Interventions
Phase One: Mental Health Problem Observation Group (Cross-sectional Study):None
Phase Two: Observation Group Under Continuous Stress (Cross-sectional Study):None
Phase Three: Experimental Group:Online Well-being Therapy
Phase Three: Control Group:Online psychological education
Sponsors
Ningcheng County Central Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Phase 1: Age >= 16 years old; Resided in China during the survey period; Able to read and complete the online questionnaire; Voluntarily participated in the study and confirmed informed consent online; Completed all the questionnaires. Phase 2: Age 18 years old and above; Voluntarily participated; Confirmed consent actively after reading the electronic informed consent information. Phase 3: Originated from medical workers who received questionnaire surveys during the epidemic; Age 20-60 years old, gender not limited; Native language is Chinese, able to understand the online informed consent, questionnaire and treatment assignment requirements; Meets the suitability steady overload standard as assessed by PSI; Has stable network and video conferencing conditions, able to complete 8 online interventions and follow-up assessments; Voluntarily participated in the study and signed online or written informed consent.
Exclusion criteria
Exclusion criteria: Phase 1: Those who did not complete all the online questionnaires, those who answered the quality control math questions incorrectly; those who had a history of insomnia or mental disorders before participating in the study. Phase 2: Those who did not complete the main scale or whose main outcome could not be determined; those who answered the quality control questions incorrectly. Phase 3: Those who have a clear history of mental disorders in the past, or are currently receiving psychiatric medication; those who are currently receiving systematic psychological treatment, or have received neurostimulation treatment in the past and whose outcome judgment may be affected by the study; and any other circumstances that may affect the subjects' compliance with the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of insomnia (Phase 1);Anxiety occurrence rate (Phase 1);Incidence rate of depression (Phase 1);The incidence rate of obsessive-compulsive symptoms (first stage);The incidence rate of somatic symptoms (first stage);Incidence rate of terror and anxiety (Phase 1);Allostatic overload state (Phase 2);T2 (at the end of the 8th intervention) incidence of adaptive steady-state overload (Phase 3); | — |
Secondary
| Measure | Time frame |
|---|---|
| Scores of the relevant dimensions of the ISI, GAD-2, PHQ-2 and SCL-90-R scales (Phase 1);Stress levels (total stress and interpersonal, work, and daily stress)(Phase 2);Psychological symptoms (anxiety, depression, somatization, hostility) (Phase 2);Abnormal disease behavior (Phase 2);Social Support (Phase 2);Psychological Well-being (Phase 2);The incidence of adaptive steady-state overload at times T1, T3, and T4 (Phase 3);Changes in the scores of each dimension of PSI (Phase 3);Change in the scores of the six dimensions of PWB (Phase 3); | — |
Countries
China
Contacts
Public ContactHongxing Wang/Dongning Li
Ningcheng Center Hospital / Xuanwu Hospital of Capital Medical University
Outcome results
None listed